Preparation and Evaluation of Biodegradable Scleral Plug Containing Curcumin in Rabbit Eye

References

• Makadia HK. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers 2011;3:1377–1397.
   PubMed Web of Science ®Google Scholar
• Yasukawa T, Kimura H, Tabata Y, Ogura Y. Biodegradable scleral plugs for vitreoretinal drug delivery. Adv Drug Delivery Rev 2001;52:25–36.
   PubMed Web of Science ®Google Scholar
• Peng YJ, Kau YC, Wen CW, Liu KS, Liu SJ. Solvent‐free biodegradable scleral plugs providing sustained release of vancomycin, amikacin, and dexamethasone—an in vivo study. Journal of Biomedical Materials Research Part A 2010;94:426–432.
   PubMed Web of Science ®Google Scholar
• Souza MC, Fialho SL, Souza PA, Fulgêncio GO, Da SG, Silva-Cunha A. Tacrolimus-loaded PLGA implants: In vivo release and ocular toxicity. Curr Eye Res 2013;39:99–102.
   Web of Science ®Google Scholar
• Zhang X, Wei J, Ma P, Mu H, Wang A, Zhang L et al. Preparation and evaluation of a novel biodegradable long‐acting intravitreal implant containing ligustrazine for the treatment of proliferative vitreoretinopathy. J Pharm Pharmacol 2015;67:160–169.
   PubMed Web of Science ®Google Scholar
• Yasukawa T, Kimura H, Tabata Y, Miyamoto H, Honda Y, Ogura Y. Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits. Albrecht Von Graefes Arch Ophthalmol 2002;240:672–678.
   Google Scholar
• Eiji S, Miho N, Komei O, Noriyuki K, Hideya K, Yuichiro O. Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis. Invest Ophthalmol Vis Sci 2003;44:4845–4852.
   PubMed Web of Science ®Google Scholar
• Peng YJ, Kau YC, Wen CW, Liu KS, Liu SJ. Solvent-free biodegradable scleral plugs providing sustained release of vancomycin, amikacin, and dexamethasone–an in vivo study. J Biomed Mater Res A 2010;94:426–432.
   PubMed Web of Science ®Google Scholar
• Alwan MR, Al-Dubai SAR, Al-Naggar RAM, Baobaid MF. The effect of curcumin and tocotrienol on the development of eye disease. J Appl Pharm Sci 2012;02.
   Google Scholar
• Allegri P, Mastromarino A, Neri P. Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-up. Clin Ophthalmol (Auckland, NZ) 2010;4:1201–1206.
   PubMedGoogle Scholar
• Bengmark S. Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. JPEN J Parenter Enteral Nutr 2006;30:45–51.
   PubMed Web of Science ®Google Scholar
• Gupta SK, Kumar B, Nag TC, Agrawal SS, Agrawal R, Agrawal P et al. Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. J Ocul Pharmacol Ther 2011;27:123–130.
   PubMed Web of Science ®Google Scholar
• Mazzolani F. Pilot study of oral administration of a curcumin-phospholipid formulation for treatment of central serous chorioretinopathy. Clin Ophthalmol 2012;2012.
   Google Scholar
• Mazzolani F, Togni S. Oral administration of a curcumin-phospholipid delivery system for the treatment of central serous chorioretinopathy: a 12-month follow-up study. Clin Ophthalmol 2013;7:939–945.
   PubMedGoogle Scholar
• Tamiya S, Barak Y, Umazume K, Liu L, McDonald KL, Kaplan HJ. Curcumin as adjunctive therapy for proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 2012;53:898–898.
   Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm 2007;4:807–818.
   PubMed Web of Science ®Google Scholar
• J H. Drug delivery methods for posterior segment disease. Curr Opin Ophthalmol 2007;18.
   Web of Science ®Google Scholar
• Peng YJ, Kau YC, Wen CW, Liu KS, Liu SJ. Solvent-free biodegradable scleral plugs providing sustained release of vancomycin, amikacin, and dexamethasone-An in vivo study. J Biomed Mater Res Part A 2010;94:426–432.
   PubMed Web of Science ®Google Scholar
• Alex AF, Spitznas M, Tittel AP, Kurts C, Eter N. Inhibitory effect of epigallocatechin gallate (EGCG), resveratrol, and curcumin on proliferation of human retinal pigment epithelial cells in vitro. Curr Eye Res 2010;35:1021–1033.
   PubMed Web of Science ®Google Scholar
• Li L, Braiteh FS, Kurzrock R. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 2005;104:1322–1331.
   PubMed Web of Science ®Google Scholar
• Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A et al. Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy. J Nanobiotechnology 2007;5:1–18.
   PubMedGoogle Scholar
• Wu XS, N W. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers. Part II: Biodegradation. J Biomater Sci 2001;12:21–34.
   PubMed Web of Science ®Google Scholar
• Yasukawa T, Kimura H, Kunou N, Miyamoto H, Honda Y, Ogura Y, et al. Biodegradable scleral implant for intravitreal controlled release of ganciclovir. Graefes Arch Clin Exp Ophthalmol 2000;238:186–190.
   PubMed Web of Science ®Google Scholar
• Hui YN, Sorgente N, Ryan SJ. Posterior vitreous separation and retinal detachment induced by macrophages. Albrecht Von Graæes Archiv Für Ophthalmologie 1987;225:279–284.
   Google Scholar
• Hui YN, Goodnight R, Sorgente N, Ryan SJ. Fibrovascular proliferation and retinal detachment after intravitreal injection of activated macrophages in the rabbit eye. Am J Ophthalmol 1989;108:176–184.
   PubMed Web of Science ®Google Scholar
• Sun Y, You ZP. Curcumin inhibits human retinal pigment epithelial cell proliferation. Int J Mol Med 2014;34:1013–1019.
   PubMed Web of Science ®Google Scholar
• Alex AF, Manfred S, Tittel AP, Christian K, Nicole E. Inhibitory effect of epigallocatechin gallate (EGCG), resveratrol, and curcumin on proliferation of human retinal pigment epithelial cells in vitro. Curr Eye Res 2010;35:1021–1033.
   PubMed Web of Science ®Google Scholar
• Thakur A, Kompella UB. Drug delivery systems for diseases of the back of the eye. Treat Ocular Drug Deliv 2013;1:114–139.
   Google Scholar
• Vaishya RD, Gokulgandhi M, Patel S, Minocha M, Mitra AK. Novel dexamethasone-loaded nanomicelles for the intermediate and posterior segment uveitis. AAPS Pharm Sci Technol 2014;15:1238–1251.
   PubMed Web of Science ®Google Scholar
• Kompella UB, Amrite AC, Pacha Ravi R, Durazo SA. Nanomedicines for back of the eye drug delivery, gene delivery, and imaging. Prog Retinal Eye Res 2013;36:172–198.
   PubMed Web of Science ®Google Scholar